Business profile

Karhu Pharma Oy

Karhu Pharma Oy's registered office is Pori. It is a limited company. The company was established on 2016-08-11. It operates in the industry of other financial service activities, except insurance and pension funding n.e.c.. In its latest retained statement for 2025-12-31, revenue was €0 and operating profit was -€1,659.

Claim profileContact details
Business ID 2770705-7ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
2770705-7
Sector
Other financial service activities, except insurance and pension funding n.e.c.
Municipality
Pori
Company form
Limited company
Registration date
2016-08-11
Business ID registration date
2016-06-29
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Itäkeskuksenkaari 6, 28130, Pori

About Karhu Pharma Oy

Financial position and key figures for the company.

Karhu Pharma Oy's location municipality is Pori. It is a limited company. The company was established on 2016-08-11. It operates in the industry of other financial service activities, except insurance and pension funding n.e.c.. In its latest retained statement for 2025-12-31, revenue was €0 and operating profit was -€1,659. The latest retained financial statement for 2025-12-31 shows revenue of €0 and profit for the financial year of €33,276. Based on the latest retained statement, revenue growth was -100.0%, operating margin was not currently available, and equity ratio was +99.8%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods4
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth-100.0%
Equity ratio99.8%
Revenue€0-€1,166,728 (-100.0%) vs previous periodPrevious: €1,166,728
Operating profit (loss)-€1,659-€178,564 (-100.9%) vs previous periodPrevious: €176,905
Profit (loss) for the financial year€33,276-€137,468 (-80.5%) vs previous periodPrevious: €170,743
Assets€2,314,935-€108,799 (-4.5%) vs previous periodPrevious: €2,423,734
Balance-sheet contextLatest financial period
Other operating income€5,704Previous: €0
Cash and bank€660,808Previous: €953,292
Retained earnings€2,275,065Previous: €2,245,298
Equity€2,310,841Previous: €2,418,541
Liabilities€4,094Previous: €5,193
Current assets€2,314,835Previous: €2,387,839
Current liabilities€4,094Previous: €5,193
Revenue trend2 periods
€1,166,728
2024-12-31
€0
2025-12-31
Operating profit (loss) trend2 periods
€176,905
2024-12-31
-€1,659
2025-12-31
Profit (loss) for the financial year trend2 periods
€170,743
2024-12-31
€33,276
2025-12-31
Assets trend2 periods
€2,423,734
2024-12-31
€2,314,935
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
99.8 %2024-12-31: 99.8 %
Current ratioGood
100/100 · Declining
161.41x2024-12-31: 183.57x
Operating profit marginWeak
0/100 · Declining
-29.1 %2024-12-31: 15.2 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio99.8 %99.8 %
Current ratio183.57x161.41x
Operating profit margin15.2 %-29.1 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID2770705-7
EU IDFIFPRO.2770705-7
MunicipalityPori
Current registered entries
2016-08-11Registered in Patent and Registration Office (Trade Register)
2016-08-16Registered in Tax Administration (Tax Administration)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B1
StableKarhu Pharma Oy
Grade unchangedB1 · new analysis 2026-10-17
Model score67/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectorySeveral key financial indicators have weakened across comparable fiscal periods.
2 comparable periods
RevenueDeteriorating
ProfitabilityDeteriorating
SolvencyStable
LiquidityDeteriorating
Peer comparisonSame industryDescriptive comparison – does not change the model score.
73 peers
Solvency90%
Better than 90% of peers
Profitability11%
Below 89% of peers
Liquidity95%
Better than 95% of peers
Revenue growth3%
Below 97% of peers
Financial statement reporting patternRegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
4 observed filings
Latest registration lag73 days after period end
Typical registration lag87 days after period end
Annual continuity2 consecutive periods
Supporting factors
  • Strong equity ratio
  • Healthy short-term liquidity
  • Company context reduces the weight of an isolated financial signal
Risk factors to note
  • Negative profitability or net result
  • Sharp year-over-year revenue drop
  • Coordinated deterioration across 3 financial domains
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessments
B1
2026-10-1767/100 · v0.15
B1 → B1
B1
2026-09-21 13:3067/100 · v0.14
A3 → B1 · -5 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2025-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
A3
2026-09-1472/100 · v0.14
A3 → A3
A3
2026-09-1472/100 · v0.13
Oldest retained automatic assessment in this comparison
Automatic model gradeB1
Automatic model snapshot2026-10-17
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
89/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityVakiintunut
80/100

The company has about 10 years of registry continuity.

Registry and status signalsSeurattava
69/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
21 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3 → B1.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.
Risk grade updatedRisk gradeEvidence verified
13 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

16 register eventsLatest event: 2026-03-14

Financial statements availability

Available financial statement periods and PRH source filings.

4 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Karhu Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.